FDA AI Search: Making FDA-Authorized AI Devices Searchable
Arun Kavishwar, William Lotter
TL;DR
The paper tackles the challenge of locating FDA-authorized AI-enabled medical devices by introducing FDA AI Search, a semantic-search platform that converts authorization summaries and device metadata into text embeddings via LLM-derived features. It combines seven device-feature embeddings with BM25 in a hybrid scoring function, Score(q,d) = (λ/∑ w_i) ∑ w_i sim(e_q, e_d^i) + (1−λ) BM25(q,d), with weights and λ optimized through Bayesian optimization and grid search. Quantitative evaluation on a curated 140-device dataset shows the hybrid approach yields superior ranking and high Hit@K values, while qualitative examples demonstrate the practical advantage of semantic over keyword search and sub-second query latency. The system aims to assist clinicians and developers in aligning device selection with clinical needs and is designed to adapt as the FDA device list evolves, with acknowledged limitations from potential LLM biases and future user studies.
Abstract
Over 1,200 AI-enabled medical devices have received marketing authorization from the U.S. FDA, yet identifying devices suited to specific clinical needs remains challenging because the FDA's databases contain only limited metadata and non-searchable summary PDFs. To address this gap, we developed FDA AI Search, a website that enables semantic querying of FDA-authorized AI-enabled devices. The backend includes an embedding-based retrieval system, where LLM-extracted features from authorization summaries are compared to user queries to find relevant matches. We present quantitative and qualitative evaluation that support the effectiveness of the retrieval algorithm compared to keyword-based methods. As FDA-authorized AI devices become increasingly prevalent and their use cases expand, we envision that the tool will assist healthcare providers in identifying devices aligned with their clinical needs and support developers in formulating novel AI applications.
